AZNAX
Price
$12.33
Change
-$0.01 (-0.08%)
Updated
Jun 22 closing price
Net Assets
4.9B
RLBFX
Price
$40.85
Change
-$0.13 (-0.32%)
Updated
Jun 22 closing price
Net Assets
287.61B
Interact to see
Advertisement

AZNAX vs RLBFX

AZNAX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
AZNAX vs. RLBFX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNAX is a StrongBuy and RLBFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 288B vs. AZNAX (4.91B). AZNAX (2.07) and RLBFX (2.02) have matching dividends . AZNAX was incepted earlier than RLBFX: AZNAX (19 years) vs RLBFX (24 years). AZNAX (1.14) is less costly to investors than RLBFX (0.30). AZNAX is a more actively managed with annual turnover of: 76.00 vs. RLBFX (50.00). RLBFX has a lower initial minimum investment than AZNAX: RLBFX (250) vs AZNAX (2500). RLBFX annual gain was more profitable for investors over the last year : 17.07 vs. AZNAX (14.45). RLBFX return over 5 years is better than : 37.80 vs. AZNAX (4.30).
AZNAXRLBFXAZNAX / RLBFX
Total Expense Ratio1.140.30380%
Annual Report Gross Expense Ratio1.140.30380%
Fund Existence19 years24 years-
Gain YTD7.4669.53678%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.91B288B2%
Annual Yield % from dividends2.072.02103%
Returns for 1 year14.4517.0785%
Returns for 3 years26.4245.6158%
Returns for 5 years4.3037.8011%
Returns for 10 years42.4493.6545%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE0.790.08
+11.06%
Aprea Therapeutics
BIIB199.713.13
+1.59%
Biogen
CPRX31.390.01
+0.03%
Catalyst Pharmaceuticals
ESPR3.15N/A
N/A
Esperion Therapeutics
BZUN2.72-0.06
-2.33%
Baozun